Stockreport

Biofrontera Kicks Off US Clinical Study Program for Ameluz®

Biofrontera Inc.  (BFRI) 
PDF WOBURN, MA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of der [Read more]